BACKGROUND. Preinjection of a nonlabeled tumor
Dosimetry of fractionated experimental radioimmunotargeting with idiotypic and anti-idiotypic anticytokeratin antibodies
✍ Scribed by Rauni Rossi Norrlund; Anders Ullén; Per Sandström; Daniel Holback; Lennart Johansson; Torgny Stigbrand; Sven-Ola Hietala; Katrine Riklund Åhlström
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 274 KB
- Volume
- 80
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
✦ Synopsis
anticytokeratin monoclonal antibody (TS1) and a nonlabeled antiidiotypic monoclonal antibody against TS1 (aTS1) were compared with a single injection of the Per Sandstro ¨m, B.Sc. 2 Daniel Holback, B
📜 SIMILAR VOLUMES
## Abstract The monoclonal antibody TS1 against cytokeratin 8 and its antiidiotype αTS1 have been used for immunotargeting and therapy of carcinomas in experimental tumor model systems. The interaction surfaces between mab TS1, the cytokeratin 8 epitope, and its anti‐idiotypic antibody, αTS1, were
Previous investigations have suggested that pairs of peptides specified by complementary RNA sequences (termed complementary peptides) can interact with one another. In the light of this finding, we hypothesized that an antibody directed against a peptide might interact with an antibody against its